-
公开(公告)号:DK1015467T3
公开(公告)日:2004-05-03
申请号:DK98944680
申请日:1998-09-01
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , CLARK RICHARD F , CHU DANIEL T , PLATTNER JACOB J
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , A61K31/70
Abstract: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula (I) (II), (III), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.
-
公开(公告)号:AT257484T
公开(公告)日:2004-01-15
申请号:AT98944680
申请日:1998-09-01
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , CLARK RICHARD F , CHU DANIEL T , PLATTNER JACOB J
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , A61K31/70
Abstract: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula (I) (II), (III), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.
-
公开(公告)号:AT217309T
公开(公告)日:2002-05-15
申请号:AT94929998
申请日:1994-09-30
Applicant: ABBOTT LAB
Inventor: CHU DANIEL T , LI QUN , COOPER CURT S , FUNG ANTHONY K L , LEE CHEUK M , PLATTNER JACOB J
IPC: C07D491/052 , A61K31/40 , A61K31/435 , A61K31/495 , A61K31/54 , A61K38/00 , A61P31/04 , C07D213/61 , C07D213/68 , C07D455/02 , C07D471/04 , C07D491/107 , C07D491/113 , C07D491/16 , C07D519/00 , C07K5/06 , A61K31/535
Abstract: Antibacterical coumpounds having formula (I) and the pharmaceutically acceptable salts, esters and amides thereof, preferred examples of which include those coumpounds wherein R is cycloalkyl of from three to eight carbon atoms or substituted phenyl; R is selected from the group consisting of (a) halogen, (b) loweralkyl, (c) loweralkenyl, (d) cycloalkyl of from three to eight carbons, (e) cycloalkenyl of from four to eight carbons, (f) loweralkoxy, (g) aryloxy, (h) aryl(loweralkyl)oxy, (i) aryl(loweralkyl), (j) cycloalkyl(loweralkyl), (k) amino, (l) (loweralkyl)amino, (m) aryl(loweralkyl)amino, (n) hydroxy substituted (loweralkyl)amino, (o) phenyl, (p) substituted phenyl, (q) bicyclic nitrogen-containing heterocycle, (r) nitrogen-containingaromatic heterocycle, and (s) nitrogen-containing heterocycle having formula (Ia) where x is between zero and three; R is halogen; R is hydrogen, loweralkyl, a pharmaceutically acceptable cation, or a prodrug ester group; R is hydrogen, loweralkyl, halo(loweralkyl), or -NR R ; and R is loweralkyl, as wellas pharmaceutical compositions containing such compounds and the use of the same in the treatment of bacterial infections.
-
公开(公告)号:HK1031383A1
公开(公告)日:2001-06-15
申请号:HK01100816
申请日:2001-02-05
Applicant: ABBOTT LAB
Inventor: PHAN LY TAM , OR YAT SUN , CHU DANIEL T , PLATTNER JACOB J , CLARK RICHARD F , CHEN YAN
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , C07H , A61K
Abstract: Novel 2-halo-6-O-substituted ketolide derivatives and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.
-
公开(公告)号:SK6172000A3
公开(公告)日:2001-03-12
申请号:SK6172000
申请日:1998-10-30
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , PLATTNER JACOB J
IPC: C07H17/00 , A61K20060101 , A61K31/00 , A61K31/70 , A61K31/7042 , A61K31/7048 , A61K31/7052 , A61P9/10 , A61P35/00 , C07D20060101 , C07H17/08
Abstract: A method for treating tumors and macular degeneration in a human or veterinary patient comprising administering a compound selected from the group consisting of (I), (II), (III), (IV), (V), (VI), (VII), and a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound thereof.
-
公开(公告)号:PL340604A1
公开(公告)日:2001-02-12
申请号:PL34060498
申请日:1998-10-30
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , PLATTNER JACOB J
IPC: C07H17/00 , A61K20060101 , A61K31/00 , A61K31/70 , A61K31/7042 , A61K31/7048 , A61K31/7052 , A61P9/10 , A61P35/00 , C07D20060101 , C07H17/08
Abstract: A method for treating tumors and macular degeneration in a human or veterinary patient comprising administering a compound selected from the group consisting of (I), (II), (III), (IV), (V), (VI), (VII), and a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound thereof.
-
公开(公告)号:AU729348B2
公开(公告)日:2001-02-01
申请号:AU4178097
申请日:1997-09-02
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , MA ZHENKUN , CLARK RICHARD F , CHU DANIEL T , PLATTNER JACOB J
IPC: A61K31/70 , A61K31/7048 , A61P31/04 , C07H17/00 , C07H17/08
Abstract: 6-Substituted ketolides of e.g. formula (II) or (III), and their salts, esters and prodrugs are new: Y + Z = X; X = OH, =NOR1 or =NOC(R5)(R6)OR1; or one of Y and Z = H; and the other = H, OH, protected OH or NR7R8; R1 = 1-12C alkyl (optionally substituted), 3-12C cycloalkyl or SiR2R3R4; R2-R4 = 1-12C alkyl or aryl; R5, R6 = H or 1-12C alkyl (optionally substituted), or R5 + R6 = 3-12C cycloalkyl; R7, R8 = H or 1-6C alkyl; or NR7R8 = 3-7 membered ring which, when the ring is 5-7 membered may optionally contain O, NH, N(1-6C alkyl), N(aryl), N(aryl-1-6C alkyl), N (substituted aryl-1-6C alkyl), N(heteroaryl), N(heteroaryl-1-6C alkyl), N(substituted heteroaryl-1-6C alkyl), S or S(O)n; n = 1 or 2; Ra = H or OH; Rc = H or hydroxy protecting group; R9 = 1-6C alkyl (optionally substituted), 3-7C cycloalkyl or optionally substituted aryl or heteroaryl; M = CONH, NHCO, NH, N=, NMe, NHCOO, NHCONH, OCONHY, OCOO, O, S(O)n, COO, OCO or CO; R = methyl (substituted by CN, F, CO2R10, S(O)nR10, NHCOR10, NHCONR11R12, aryl, substituted aryl, heteroaryl or substituted heteroaryl); 2-10C alkyl (optionally substituted), 3C alkenyl (substituted by halo, CHO, CO2R10, COR9, CONR11R12, CN, optionally substituted aryl or heteroaryl, 3-7C cycloalkyl or 1-12C alkyl substituted by heteroaryl); 4-10C alkenyl (optionally substituted), or 3-10C alkynyl optionally substituted); R10 = 1-3C alkyl (optionally aryl substituted), or heteroaryl substituted 1-3C alkyl; R11, R12 = H or 1-3C alkyl (optionally substituted); A, B, D, E = H, 1-6C alkyl (optionally substituted by optionally substituted), 3-7C cycloalkyl, optionally substituted aryl or heteroaryl, heterocycloalkyl or 1-6C alkyl substituted by MR9; provided that \- 2 of A, B, D and E = H; or any one pair of substituents, consisting of AB, AD, AE, BD, BE or DE taken with the atoms to which they are attached, form a 3- to 7-membered ring optionally containing O, NH, N(1-6C alkyl), N(aryl-1-6C alkyl), N(substituted aryl-1-6C alkyl), N(heteroaryl-1-6C alkyl), N(substituted heteroaryl-1-6C alkyl), S, S(O)n, CONH, CONR12, NHCO, NR12CO or C(=NH)NH.
-
公开(公告)号:GR3034694T3
公开(公告)日:2001-01-31
申请号:GR20000402381
申请日:2000-10-27
Applicant: ABBOTT LAB
Inventor: CHU DANIEL T , LEE CHEUK M , LI QUN , COOPER CURT S , PLATTNER JACOB J
IPC: A61K31/435 , A61K31/47 , A61K31/505 , A61K31/535 , A61K31/54 , A61K38/00 , A61P31/04 , C07D213/68 , C07D455/02 , C07D471/04 , C07D471/08 , C07D491/10 , C07D491/16 , C07D495/16 , C07D519/00 , C07K5/06 , A61K31/44 , A61K31/495 , C07D239/70 , C07D279/12 , C07D413/00 , C07D417/00 , C07D491/00 , C07D498/00
-
公开(公告)号:BG104288A
公开(公告)日:2001-01-31
申请号:BG10428800
申请日:2000-03-30
Applicant: ABBOTT LAB
Inventor: OR YAT S , CLARK RICHARD R , CHU DANIEL T , PLATTNER JACOB J
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , A61K31/70
Abstract: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formulae compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention. 10 claims
-
公开(公告)号:SK6332000A3
公开(公告)日:2000-09-12
申请号:SK6332000
申请日:1998-10-29
Applicant: ABBOTT LAB
Inventor: PHAN LY TAM , OR YAT SUN , CHU DANIEL T , PLATTNER JACOB J , CHEN YAN , CLARK RICHARD F
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , A61K31/70
Abstract: Novel 2-halo-6-O-substituted ketolide derivatives and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.
-
-
-
-
-
-
-
-
-